AngioDynamics Newsroom

CCORF Maintains AngioDynamics(ANGO.US) With Buy Rating, Maintains Target Price $12

Futu NewsOct 23 20:34

Analysts Offer Insights on Healthcare Companies: Incyte (INCY), Otsuka Holdings Co (OtherOTSKF) and AngioDynamics (ANGO)

TipRanksOct 23 20:13

Oppenheimer Maintains AngioDynamics(ANGO.US) With Buy Rating, Maintains Target Price $13

Futu NewsOct 5 10:32

AngioDynamics Is Maintained at Buy by Canaccord Genuity

Dow JonesOct 4 22:53

AngioDynamics Price Target Cut to $12.00/Share From $13.00 by Canaccord Genuity

Dow JonesOct 4 22:53

AngioDynamics Analyst Ratings

BenzingaOct 4 22:43

H.C. Wainwright Maintains AngioDynamics(ANGO.US) With Buy Rating, Maintains Target Price $14

Futu NewsOct 4 21:33

AngioDynamics (ANGO) Gets a Buy From H.C. Wainwright

TipRanksOct 4 21:29

CCORF Maintains AngioDynamics(ANGO.US) With Buy Rating, Cuts Target Price to $12

Futu NewsOct 4 19:31

H.C. Wainwright Maintains AngioDynamics(ANGO.US) With Buy Rating, Maintains Target Price $14

Futu NewsSep 20 18:31

AngioDynamics Analyst Ratings

BenzingaSep 20 18:30

HC Wainwright & Co. Reiterates Buy on AngioDynamics, Maintains $14 Price Target

BenzingaSep 20 18:30

Buy Rating Affirmed for AngioDynamics Following Positive Trial Outcomes and Market Expansion Potential

TipRanksSep 20 18:29

Canaccord Genuity Maintains Buy on AngioDynamics, Lowers Price Target to $13

BenzingaJul 18 03:24

Analysts Offer Insights on Healthcare Companies: Teladoc (TDOC), Argenx Se (ARGX) and AngioDynamics (ANGO)

TipRanksJul 17 23:34

HC Wainwright & Co. Reiterates Buy on AngioDynamics, Maintains $14 Price Target

BenzingaJul 17 18:07

AngioDynamics Analyst Ratings

BenzingaJul 17 18:05

AngioDynamics Analyst Ratings

BenzingaMay 22 20:06

HC Wainwright & Co. Reiterates Buy on AngioDynamics, Maintains $14 Price Target

BenzingaMay 22 20:05

Buy Rating on AngioDynamics: Growth and Regulatory Approvals Underscore Positive Outlook

TipRanksMay 22 18:35